Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 1/20 | 0.64 |
| ▸ | MAOB | P27338 | 2/20 | 0.59 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.56 |
| ▸ | CTSL | P07711 | 1/20 | 0.56 |
| ▸ | CTSB | P07858 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | BCHE | P06276 | 2/20 | 0.55 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.55 |
| ▸ | TNFRSF1A | P19438 | 1/20 | 0.55 |
| ▸ | ACHE | P22303 | 1/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | PLIN5 | Q00G26 | 1/20 | 0.55 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.55 |
| ▸ | ABHD5 | Q8WTS1 | 1/20 | 0.55 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.53 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23610336 | 1.00 | TYR (0.64) | TYRMAOBCAPN1CTSLCTSB | |
| SCHEMBL30872967 | 0.86 | IAPP (0.62) | TYRMAOBMAPTLMNABCHE | |
| SCHEMBL7925826 | 0.86 | IAPP (0.62) | TYRMAOBMAPTLMNABCHE | |
| SCHEMBL1073514 | 0.86 | IAPP (0.62) | TYRMAOBMAPTLMNABCHE | |
| SCHEMBL4460729 | 0.86 | CHRNA7 (0.68) | TYRMAOBCAPN1CTSLCTSB | |
| SCHEMBL4460724 | 0.86 | CHRNA7 (0.68) | TYRMAOBCAPN1CTSLCTSB | |
| SCHEMBL7191588 | 0.85 | TYR (0.59) | TYRMAOBCAPN1CTSLCTSB | |
| SCHEMBL7191590 | 0.85 | TYR (0.59) | TYRMAOBCAPN1CTSLCTSB | |
| SCHEMBL636139 | 0.85 | TYR (0.62) | TYRMAOBMAPTLMNABCHE | |
| Hydrochloric Acid SCHEMBL4426609 | 0.85 | IAPP (0.60) | TYRMAOBMAPTLMNABCHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 405 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4496476-A1 | GAS PHASE TREATMENT OF PRODUCE | Apeel Technology, Inc. (US) | 2025-01-29 | — | — | EP | claimed |
| CN-117320559-A | Edible coating with antimicrobial properties | 阿比尔技术公司 | 2023-12-29 | — | — | CN | claimed |
| WO-2023183341-A1 | GAS PHASE TREATMENT OF PRODUCE | APEEL TECHNOLOGY, INC. (US) | 2023-09-28 | — | — | WO | claimed |
| CN-112176368-B | Potassium chloride acidic zinc plating electroplating solution and application thereof | 武汉奥邦表面技术有限公司 | 2021-07-09 | — | — | CN | claimed |
| CN-112176368-A | Potassium chloride acidic zinc plating electroplating solution and application thereof | 武汉奥邦表面技术有限公司 | 2021-01-05 | — | — | CN | claimed |
| CN-106107406-B | Methods of improving the stability of sweetness enhancers and compositions comprising stable sweetness enhancers | 弗门尼舍公司 | 2020-06-09 | — | — | CN | claimed |
| CN-109535118-A | A kind of synthetic method of fisetin | 陕西嘉禾生物科技股份有限公司 | 2019-03-29 | — | — | CN | claimed |
| US-20190008797-A1 | ESTROGEN RECEPTOR ALPHA COLIGANDS, AND METHODS OF USE THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2019-01-10 | — | — | US | claimed |
| CN-108467699-A | A kind of Optical adhesive composition and preparation method thereof | 苏州盛达胶粘制品有限公司 | 2018-08-31 | — | — | CN | claimed |
| US-20170367974-A1 | Polymer Implants For Treatment Of Metabolic Disorders | UNIVERSITY OF SOUTH CAROLINA | 2017-12-28 | — | — | US | claimed |
| EP-1954681-A2 | COMPOUNDS AND METHODS FOR THIOL-CONTAINING COMPOUND EFFLUX AND CANCER TREATMENT | National Jewish Medical and Research Center (US) | 2008-08-13 | — | — | EP | claimed |
| WO-2007073518-A9 | COMPOUNDS AND METHODS FOR THIOL-CONTAINING COMPOUND EFFLUX AND CANCER TREATMENT | NAT JEWISH MED & RES CENTER (US) | 2007-08-23 | — | — | WO | claimed |
| WO-2007073518-A2 | COMPOUNDS AND METHODS FOR THIOL-CONTAINING COMPOUND EFFLUX AND CANCER TREATMENT | NATIONAL JEWISH MEDICAL AND RESEARCH CENTER (US) | 2007-06-28 | — | — | WO | claimed |
| CN-1816328-A | Therapeutic agent | TAKARA BIO INC (JP) | 2006-08-09 | — | — | CN | claimed |
| US-20060135585-A1 | Compounds and methods for thiol-containing compound efflux and cancer treatment | NATIONAL JEWISH MEDICAL AND RESEARCH CENTER (US) | 2006-06-22 | — | — | US | claimed |
| EP-1478757-A2 | PRODUCTION OF DADZEIN IN TRANSGENIC PLANTS | UNILEVER PLC (GB) | 2004-11-24 | — | — | EP | claimed |
| WO-2003072790-A2 | PRODUCTION OF DADZEIN IN TRANSGENIC PLANTS | UNILEVER PLC (GB) | 2003-09-04 | — | — | WO | claimed |
| CN-1087609-C | Chalcones and esters thereof with antiproliferative activity in uterus, ovary and breast tumors | INDENA SPA (IT) | 2002-07-17 | — | — | CN | claimed |
| CN-1170362-A | Chalcones and esters thereof with antiproliferative activity in uterus, ovary and breast tumours | INDENA SPA (IT) | 1998-01-14 | — | — | CN | claimed |
| CN-1095590-A | By parasite or bacterial treatment of diseases and prevention | STATENS SERUMINSTITUT (DK) | 1994-11-30 | — | — | CN | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060135585-A1 | Compounds and methods for thiol-containing compound efflux and cancer treatment | ABCC1, ABCC2, ABCB1 | TYR 4795/4885MAOB 3654/4885CAPN1 2068/4885 |
| US-20170367974-A1 | Polymer Implants For Treatment Of Metabolic Disorders | LRBA, FABP4, APMAP | TYR 4660/4885MAOB 3615/4885CAPN1 4542/4885 |
| US-20190008797-A1 | ESTROGEN RECEPTOR ALPHA COLIGANDS, AND METHODS OF USE THEREOF | ESRRG, GPER1, ESR2 | TYR 4427/4885MAOB 3735/4885CAPN1 411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.